The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 1.11

Age Distribution (%) of Incidence Cases by Site, 2011-2015
All Races, Both Sexes

Site Ages <20 Ages 20-34 Ages 35-44 Ages 45-54 Ages 55-64 Ages 65-74 Ages 75-84 Ages 85+ All Ages Number of Cases
All Sites 1.0 2.8 5.0 13.3 24.6 27.2 18.3 7.9 100.0% 2,087,262
Oral Cavity & Pharynx: 0.5 1.9 4.5 17.5 30.8 24.5 14.0 6.3 100.0% 55,070
Lip 0.1 1.4 3.9 13.9 21.2 24.0 22.2 13.2 100.0% 3,241
Tongue 0.1 1.6 3.8 17.0 33.8 26.1 12.8 4.7 100.0% 16,883
Salivary gland 1.9 6.0 7.4 12.7 19.0 23.2 18.5 11.3 100.0% 6,048
Floor of mouth 0.1 0.4 2.3 18.1 35.3 25.6 13.4 4.8 100.0% 2,438
Gum & other oral cavity 0.6 1.7 4.0 11.9 22.9 25.0 21.3 12.5 100.0% 7,179
Nasopharynx 2.8 6.3 12.4 22.8 26.6 18.4 8.5 2.3 100.0% 2,904
Tonsil 0.0 0.4 4.3 25.4 40.3 21.3 6.7 1.5 100.0% 10,093
Oropharynx 0.2 0.3 2.8 18.2 34.0 28.3 12.2 4.0 100.0% 2,198
Hypopharynx 0.0 0.2 1.1 14.5 33.1 30.4 15.8 4.9 100.0% 2,814
Other oral cavity & pharynx 0.3 0.9 2.7 16.8 31.0 26.3 14.9 7.1 100.0% 1,272
Digestive System: 0.2 1.2 3.5 13.0 24.5 25.9 20.9 10.7 100.0% 386,637
Esophagus 0.0 0.4 1.9 10.4 27.1 30.6 21.2 8.5 100.0% 20,146
Stomach 0.1 1.7 4.3 11.9 21.5 26.3 22.7 11.4 100.0% 33,965
Small intestine 0.1 1.7 4.8 14.7 24.9 27.4 19.0 7.3 100.0% 10,894
Colon & Rectum: 0.2 1.6 4.4 15.0 22.6 24.3 20.6 11.4 100.0% 186,532
Colon 0.2 1.5 3.8 12.6 20.6 25.0 23.0 13.3 100.0% 130,439
Rectum 0.1 1.9 5.8 20.6 27.0 22.7 15.0 7.1 100.0% 56,093
Colon & Rectum (Male) 0.1 1.5 4.3 15.7 24.9 25.9 19.1 8.4 100.0% 97,424
Colon & Rectum (Female) 0.2 1.7 4.4 14.3 20.0 22.7 22.2 14.7 100.0% 89,108
Anus, anal canal & anorectum 0.0 1.2 5.3 21.7 30.2 22.4 13.2 6.0 100.0% 8,965
Liver & intrahepatic bile duct 0.8 0.7 1.8 12.1 37.1 25.8 15.9 5.9 100.0% 44,172
Gallbladder 0.0 0.5 2.4 9.3 20.5 27.8 25.7 13.7 100.0% 5,539
Other biliary 0.1 0.6 2.5 8.2 20.7 27.3 26.6 14.0 100.0% 8,891
Pancreas 0.1 0.5 1.9 8.6 22.4 28.4 24.7 13.4 100.0% 59,942
Retroperitoneum 7.5 4.5 5.1 16.4 23.0 23.8 14.8 4.9 100.0% 1,767
Peritoneum, omentum & mesentery 0.3 1.2 1.9 10.9 24.9 32.7 21.0 7.2 100.0% 2,543
Other digestive system 0.2 0.8 2.7 9.3 21.6 26.0 25.5 14.0 100.0% 3,281
Respiratory System: 0.1 0.3 1.2 7.8 22.2 33.0 26.1 9.2 100.0% 275,950
Nose, nasal cavity & middle ear 1.7 3.4 7.4 15.0 23.5 22.6 18.1 8.5 100.0% 3,204
Larynx 0.0 0.4 2.1 13.5 31.4 30.0 17.1 5.6 100.0% 14,536
Lung & bronchus 0.0 0.2 1.0 7.4 21.7 33.4 26.8 9.4 100.0% 257,301
Lung & bronchus (Male) 0.0 0.2 1.0 7.0 22.7 34.0 26.4 8.6 100.0% 133,651
Lung & bronchus (Female) 0.0 0.3 1.1 7.7 20.6 32.7 27.3 10.3 100.0% 123,650
Pleura 1.4 2.2 4.3 5.1 15.9 21.7 31.9 17.4 100.0% 138
Trachea & other respiratory organs 17.1 20.0 8.0 10.0 14.5 14.8 10.5 5.1 100.0% 771
Bones & joints 27.3 15.4 9.4 12.1 12.8 11.7 7.6 3.7 100.0% 4,207
Soft tissue (including heart) 8.3 9.0 8.5 14.2 19.5 18.3 14.6 7.5 100.0% 15,839
Skin (excl. basal & squamous): 0.5 5.4 7.4 14.6 21.8 23.4 17.7 9.1 100.0% 116,628
Melanoma of the skin 0.4 5.5 7.6 15.1 22.4 23.5 17.1 8.3 100.0% 107,109
Other non-epithelial skin 1.3 4.9 5.2 8.8 14.8 22.1 25.3 17.8 100.0% 9,519
Breast (Female) 0.0 1.9 8.6 20.4 25.9 24.1 13.6 5.5 100.0% 317,468
Breast (Female -in situ) 0.0 0.7 9.5 26.4 27.9 23.7 9.8 1.9 100.0% 77,965
Female Genital System: 0.4 4.0 8.1 17.5 29.1 23.3 12.3 5.4 100.0% 125,897
Cervix uteri 0.1 14.0 23.6 23.4 19.1 11.4 5.9 2.5 100.0% 16,935
Corpus uteri 0.0 1.7 5.4 16.3 35.0 26.8 11.2 3.7 100.0% 66,066
Uterus, NOS 0.2 1.9 5.5 16.1 24.6 22.7 16.3 12.7 100.0% 2,147
Ovarya 1.3 4.0 6.8 18.1 24.6 22.1 15.3 7.7 100.0% 29,281
Vagina 1.0 1.6 4.7 13.0 23.1 24.4 19.6 12.6 100.0% 1,868
Vulva 0.1 1.7 5.2 14.5 20.6 22.0 21.1 14.8 100.0% 6,374
Other female genital system 0.5 4.5 3.9 13.4 25.5 27.2 17.4 7.6 100.0% 3,226
Male Genital System: 0.3 2.3 1.6 9.2 31.3 37.0 14.5 3.8 100.0% 272,609
Prostate 0.0 0.0 0.5 9.0 32.7 38.8 15.1 3.9 100.0% 257,650
Testis 5.7 50.5 23.1 12.9 5.5 1.7 0.5 0.2 100.0% 12,481
Penis 0.0 1.7 4.9 12.2 21.0 26.3 23.3 10.7 100.0% 1,873
Other male genital system 1.5 3.3 4.3 12.6 22.8 27.4 20.2 7.9 100.0% 605
Urinary System: 0.5 1.1 3.4 10.2 21.9 28.7 23.2 10.9 100.0% 171,139
Urinary bladder 0.1 0.4 1.3 6.1 18.3 29.8 28.8 15.1 100.0% 91,295
Kidney & renal pelvis 1.1 1.9 6.0 15.5 26.6 27.3 16.0 5.6 100.0% 75,678
Ureter 0.0 0.1 0.4 3.6 15.0 30.7 34.2 15.9 100.0% 2,433
Other urinary system 0.1 0.2 1.2 5.9 17.5 27.7 28.9 18.5 100.0% 1,733
Eye & Orbit 11.8 3.8 5.9 13.3 21.3 22.8 15.1 6.0 100.0% 4,027
Brain & Nervous System: 12.5 8.9 7.6 13.7 20.3 19.2 12.9 4.9 100.0% 29,330
Brain 11.6 8.8 7.4 13.6 20.7 19.6 13.2 5.0 100.0% 27,575
Cranial nerves & other nervous system 27.2 10.3 10.7 14.7 13.8 12.9 6.8 3.6 100.0% 1,755
Endocrine System: 2.8 14.9 18.1 22.3 20.9 13.9 5.6 1.4 100.0% 69,278
Thyroid 1.9 15.4 18.6 22.8 21.0 13.7 5.4 1.3 100.0% 65,899
Other endocrine & thymus 20.9 7.0 8.0 12.7 20.2 18.0 10.0 3.2 100.0% 3,379
Lymphoma: 2.9 6.7 6.2 12.1 20.2 23.8 19.4 8.7 100.0% 101,968
Hodgkin lymphoma 12.2 31.2 13.9 13.0 11.8 9.3 6.3 2.3 100.0% 11,324
Non-Hodgkin lymphoma 1.7 3.6 5.3 12.0 21.3 25.6 21.1 9.5 100.0% 90,644
Myeloma 0.0 0.5 2.8 10.9 23.2 29.8 23.7 9.0 100.0% 31,483
Leukemia: 8.8 4.6 4.7 9.8 17.9 23.2 20.5 10.6 100.0% 63,616
Lymphocytic: 13.2 2.8 3.2 9.2 19.2 23.6 19.1 9.8 100.0% 31,743
Acute lymphocytic 55.4 10.4 6.2 7.2 8.5 6.6 4.2 1.5 100.0% 7,535
Chronic lymphocytic 0.0 0.3 1.6 9.1 22.4 29.6 24.5 12.6 100.0% 22,377
Other lymphocytic 1.1 1.9 10.0 18.5 22.9 21.1 15.1 9.3 100.0% 1,831
Myeloid & Monocytic: 4.1 6.5 6.3 10.6 17.1 23.3 21.7 10.3 100.0% 29,539
Acute myeloid 4.9 6.0 5.3 9.5 16.9 24.3 22.6 10.5 100.0% 19,570
Chronic myeloid 2.1 7.7 8.6 13.5 17.9 21.4 19.3 9.5 100.0% 8,371
Acute monocytic 7.6 4.7 7.0 10.0 16.3 21.6 22.6 10.2 100.0% 898
Other myeloid & monocytic 3.6 7.4 5.9 8.7 14.4 21.4 22.7 15.9 100.0% 700
Other leukemia: 6.1 4.9 4.4 7.5 11.7 16.2 24.2 24.9 100.0% 2,334
Other acute leukemia 8.0 5.7 4.5 6.9 11.5 16.7 25.1 21.6 100.0% 1,031
Aleukemic, subleukemic & NOS 4.7 4.3 4.3 8.0 11.9 15.9 23.4 27.6 100.0% 1,303
Kaposi Sarcoma 0.3 24.8 19.7 21.7 10.7 8.1 8.8 6.1 100.0% 2,202
Mesothelioma 0.0 1.1 1.6 5.8 14.8 28.8 31.7 16.1 100.0% 4,233
Ill-defined & unspecified 0.4 0.9 2.2 8.0 18.9 23.8 25.7 20.0 100.0% 37,177

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.